AA
AVNS

AQR Arbitrage’s Avanos Medical AVNS Stock Holding History

AQR Arbitrage’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.3M Buy
+895,333
New +$21M 0.32% 64
2017
Q1 		– Sell
-168,421
Closed -$6.23M – 340
2016
Q4 		$6.23M Sell
168,421
-233,700
-58% -$8.35M 0.06% 172
2016
Q3 		$13.9M Sell
402,121
-107,595
-21% -$3.77M 0.14% 142
2016
Q2 		$16.6M Hold
509,716
– – 0.18% 126
2016
Q1 		$14.6M Buy
509,716
+258,743
+103% +$6.89M 0.17% 125
2015
Q4 		$8.38M Buy
+250,973
New +$7.8M 0.09% 161

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

AQR Arbitrage's AVNS Position: Q2 2026 in Review

AQR Arbitrage opened a new position in Avanos Medical (AVNS) in Q2 2026: 895,333 shares worth $22.3M. The stake represents 0.32% of the portfolio and ranks #64 among its holdings. This is a return to the name: AQR Arbitrage previously reported a position in AVNS as recently as Q4 2016.

AQR Arbitrage first reported a position in AVNS in Q4 2015 and has held it in 6 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • AQR Arbitrage held 895,333 shares of Avanos Medical worth $22.3M as of Q2 2026.
  • Avanos Medical was a new AQR Arbitrage position in Q2 2026.
  • Avanos Medical made up 0.32% of AQR Arbitrage's portfolio in Q2 2026, its #64 holding.
  • AQR Arbitrage first reported a position in Avanos Medical in Q4 2015 and has held it in 6 quarters since.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on AQR Arbitrage's 13F filing for Q2 2026, filed 14 Aug 2026.